drugset
drugset / Trial / NCT00675740

Physical Exercise Versus Rosiglitazone in CAD and Prediabetes

NCT00675740 ↗

Phase 4 Completed 45 enrolled University of Leipzig
RandomizedParallel-groupSingle-blindTreatment

Summary

The aim of this study is to prospectively assess the relative benefits of either treatment with rosiglitazone or physical exercise on endothelial function in patients with impaired fasting glucose or impaired glucose tolerance and coronary artery disease (CAD).

Timeline

Start
2004-01
Primary completion
2007-02
Completion
2007-02

Drugs

EvaluationDrugModalityDoseRoute
Subject Rosiglitazone Small molecule 4 mg —

Indications

glucose intolerance